Clinical Trials on ICD10 Code L40.9 for Psoriasis in Hungary
Total 0 results
Nothing found
Sponsors and Collaborators
- Siddhartha Ganguly
- No.2 People Hospital of Fuyang City
- Kolfarma s.r.l. - Italy
- The University of Texas System Healthcare Safety & Effectiveness Grants Program
- Evolve BioSystems, Inc.
- Dr Jérôme Rambaud, MD, PhD; Sorbonne University, Paris, France
- Universal Biosensors Pty Ltd
- Alfred Benzon Foundation
- IRCCS-Istituto delle scienze neurologiche di Bologna
- Forschungsverbund Rehabilitationswissenschaften Sachsen-Anhalt
- Penza State University
- University of Houston
- CirQuest Labs
- BioSensics LLC
- National University Polyclinics, Singapore
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Ramboll Group
- MITERA Children's Hospital
- Crovelis
- Midlothian Care Center
- View Full List
Medical Conditions
- Associated Conditions
- To Analyze the Frequency of Posttraumatic Stress Disorder in Cases With Awareness and Possible Awareness
- Tumor, Benign
- Maxillary Deficiency
- Germinal Center B-cell Type (GCB)
- Attention Deficit Hyperactivity Disorder Symptoms
- Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
- Focal Cortical Dysplasia
- Periprosthetic Fracture of the Upper or Lower Limb
- Spondylitis Secondary to Inflammatory Bowel Disease
- Benign Lymphoproliferative Disorder
- Acute Myocardial Infraction or Chest Pain
- Stimulant Use (Diagnosis)
- Severe Haemophilia A
- Intramural Haematoma of Thoracic Aorta
- Lack of Drug Action
- FIGO Stage III Primary Peritoneal Cancer
- Five-year Survival Rate
- Disorder of Nipple
- Heart Failure With Reduced Ejection Fraction (HFrEF)
- View Full List
Drug Interventions
- Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg
- GM-CSF
- G-CSF
- Golcadomide
- Human menopausal gonadotropin
- PD-0332991
- Uprifosbuvir
- Formulation N3
- Megestrol Acetate 160 MG
- Ciclesonide
- Nab-paclitaxel
- Colchicine group (experimental arm)
- Glycopyrrolate
- Mild sedation and analgesia
- Single dose of vepdegestrant as tablet formulation (Treatment A)
- Treament C
- JNJ 10229570-AAA 3.6% cream
- Administration of etoricoxib
- DKN-01
- Bevacizumab
- View Full List
CROs by country
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Iran
- Contract Research Organizations in Ireland
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Oman
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Thailand
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Uganda
- CRO list by country